How specialist retailers are redefining what value means to Australian shoppers.
Australia's retail story is usually told as a two-horse race: Coles versus Woolworths, fighting over price perception, loyalty points and private label.
The numbers coming out of three very different "discount" businesses this year tells a more interesting story.
Chemist Warehouse's newly listed parent, Sigma Healthcare, just posted first-half revenue up almost 15% to AUD5.5 bn (US$3.9bn), with sales in Chemist Warehouse stores up 17%. The Reject Shop, delisted from the ASX in 2025 after Canadian variety discounter Dollarama bought it outright, is being rebuilt as a private company with a new backer's balance sheet behind it. Aldi, the discounter that spent two decades as the disruptor, posted slowing revenue growth and a double-digit fall in profit for 2025.
Australia's value proposition has become increasingly competitive
The competitive environment has changed considerably over recent years.
Coles and Woolworths have both invested heavily in improving price perception, expanding own-brand ranges and strengthening loyalty programmes. At the same time, online grocery has become more sophisticated, giving shoppers greater visibility of prices and promotions than ever before.
Aldi is maturing
After years of double-digit growth, Aldi's Australian revenue rose 4.8% in 2025, to AUD13.9bn (US$9.8bn), while net profit fell to AUD337m (US$236m) from $417m (US$292m) the year before. Its market share has sat at roughly 8-9% for several years now, still growing but more slowly, as Woolworths and Coles have clawed back ground. Aldi's response has been telling: cutting prices on hundreds of products and planning its first major store-format overhaul in over a decade.
Chemist Warehouse is expanding in breadth of categories and its network
Since its 2025 merger with ASX-listed Sigma Healthcare, the health-and-beauty discounter has become the standout growth story in Australian retail: domestic like-for-like sales up 15%, international network sales up 24.5%, and a network that has grown to 550 stores. It is also the clearest case of a "discounter" moving upmarket without losing its price identity - expanding private label, riding the momentum with GLP-1 weight-loss drugs, entering the UK and pushing deeper into beauty and wellness categories.
The Reject Shop is being rebuilt from the inside
Dollarama's 2025 takeover pulled The Reject Shop off the ASX and installed a foreign parent with deep discount-retail experience of its own. Dollarama CEO Neil Rossy said stores will not be re-bannered until they have been renovated and management is satisfied they reflect the Dollarama customer experience. The red-and-yellow Reject Shop branding stays in place until that renovation is complete.
Dollarama emphasizes strong direct sourcing capabilities (reducing intermediary costs, increasing supplier leverage), a flexible brand-vs-private-label and import-vs-domestic mix, no loss leaders, and a multi-price-point pricing strategy.
Value is becoming increasingly mission-led
For many shoppers, value is no longer defined by finding the cheapest retailer overall.
To stay relevant, retailers are sharpening their approach to value. Coles and Woolworths have spent heavily on price-matching, expanded private label and sharper loyalty programs.
Shoppers are not relying on one retailer for the whole basket. They go to a short list of retailers they instinctively associate with a particular job: Aldi for the weekly shop, Chemist Warehouse for vitamins and skincare, Reject Shop for party supplies, household wares, cleaners and basic pet care. A household can run all three in the same week without ever thinking of them as competitors.
What happens when inflation eases
If cost-of-living pressure eases and shoppers have more bandwidth to consolidate their spending again, some of this mission-splitting behaviour could reverse in favour of convenience. Chemist Warehouse's growth also owes a lot to categories (GLP-1 weight-loss drugs, international expansion) that are new tailwinds rather than proof the discount health-and-beauty model itself is accelerating.
What it means for the next phase of competition
The clearest signal is that specialisation, not just low price, is now the more defensible position. Chemist Warehouse is proving a discounter can grow by its ability to cross sell more products. Aldi's slowdown suggests that being "the cheap one" stops working once bigger rivals close the price gap. Reject Shop's ownership change might suggest that a variety-store discounter needs new capital and operational muscle to stay relevant against Kmart and Big W, not just a loyal customer base.
For Coles and Woolworths, the lesson is not that specialists are an existential threat. It is that winning every shopping mission is no longer realistic, and defending the missions that matter most (fresh food, everyday grocery) may be worth more than chasing share everywhere at once.
Read more about how retailers are driving value around the world in Q2.
Our value framework has been updated for 2026, read about it in Reframing the value equation.